Piper upgrades Intra-Cellular on potential in major depressive disorder
PremiumThe FlyPiper upgrades Intra-Cellular on potential in major depressive disorder
13d ago
AbbVie price target raised to $209 from $196 at Piper Sandler
Premium
The Fly
AbbVie price target raised to $209 from $196 at Piper Sandler
27d ago
Eli Lilly named new top large pharma pick at Wells Fargo
Premium
The Fly
Eli Lilly named new top large pharma pick at Wells Fargo
30d ago
Texas probes CenterPoint, Starbucks in talks with Elliott: Morning Buzz
PremiumThe FlyTexas probes CenterPoint, Starbucks in talks with Elliott: Morning Buzz
1M ago
AbbVie price target raised to $218 from $211 at Morgan Stanley
Premium
The Fly
AbbVie price target raised to $218 from $211 at Morgan Stanley
1M ago
AbbVie price target raised to $218 from $211 at Morgan Stanley
Premium
The Fly
AbbVie price target raised to $218 from $211 at Morgan Stanley
1M ago
AbbVie Completes Acquisition of Cerevel Therapeutics
PremiumPress ReleasesAbbVie Completes Acquisition of Cerevel Therapeutics
2M ago
AbbVie price target raised to $210 from $195 at Truist
Premium
The Fly
AbbVie price target raised to $210 from $195 at Truist
2M ago
AbbVie announces European Commission approval of Skyrizi
Premium
The Fly
AbbVie announces European Commission approval of Skyrizi
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100